{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05848141",
            "orgStudyIdInfo": {
                "id": "IRB202201237"
            },
            "organization": {
                "fullName": "University of Florida",
                "class": "OTHER"
            },
            "briefTitle": "Rowing Following Breast Cancer Chemotherapy",
            "officialTitle": "Indoor Rowing as a Novel Exercise Therapy for Cardiovascular Rehabilitation in Middle-Aged and Older Breast Cancer Survivors Following Chemotherapy",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "rowing-following-breast-cancer-chemotherapy"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-02-26",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-05-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-05-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-03-20",
            "studyFirstSubmitQcDate": "2023-04-27",
            "studyFirstPostDateStruct": {
                "date": "2023-05-08",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-02",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-05",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "University of Florida",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "There are more than 3.8 million breast cancer survivors in the United States and cancer survivors have a higher risk of cardiovascular disease (CVD) due to chemotherapy than adults without cancer. Cardiovascular rehabilitation can be an effective strategy to decrease the incidence of CVD and its risk factors in this population. The proposed study may help to examine the effect of a novel exercise intervention on cardiovascular rehabilitation in breast cancer survivors."
        },
        "conditionsModule": {
            "conditions": [
                "Breast Cancer Survivors"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "PREVENTION",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "whoMasked": [
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 72,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Indoor Rowing",
                    "type": "EXPERIMENTAL",
                    "description": "Research participants will be instructed how to use a Concept 2 RowErg and will be provided instruction on basic rowing skills for beginners. Exercise training will gradually progress to 50 min of moderate-intensity exercise, on 3 days per week, for 12 weeks.",
                    "interventionNames": [
                        "Behavioral: Exercise training"
                    ]
                },
                {
                    "label": "Usual Care",
                    "type": "NO_INTERVENTION",
                    "description": "Research participants in this group will have the opportunity to complete the supervised indoor rowing program after completing their post-intervention assessments."
                }
            ],
            "interventions": [
                {
                    "type": "BEHAVIORAL",
                    "name": "Exercise training",
                    "description": "This is a single site center-based supervised exercise intervention.",
                    "armGroupLabels": [
                        "Indoor Rowing"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in brachial FMD",
                    "description": "Flow-mediated dilation (FMD) is an established non-invasive measure of endothelial function. Brachial artery FMD will be determined via ultrasonography in response to reactive hyperemia following 5-min forearm ischemia.",
                    "timeFrame": "Baseline, Following 12 weeks of supervised exercise training"
                },
                {
                    "measure": "Change in global longitudinal strain",
                    "description": "Global longitudinal strain is a marker of acute subclinical cardiotoxicity and is recommended for monitoring cancer patients at risk of cancer therapy-related cardiac dysfunction.",
                    "timeFrame": "Baseline, Following 12 weeks of supervised exercise training"
                },
                {
                    "measure": "% completed vs. planned exercise frequency",
                    "description": "We will collect information throughout the exercise intervention regarding % completed vs. planned exercise sessions/week.",
                    "timeFrame": "Throughout the 12 weeks of supervised exercise training"
                },
                {
                    "measure": "% completed vs. planned exercise duration",
                    "description": "We will collect information throughout the exercise intervention regarding % completed vs. planned exercise min/session.",
                    "timeFrame": "Throughout the 12 weeks of supervised exercise training"
                },
                {
                    "measure": "% completed vs. planned exercise intensity",
                    "description": "We will collect information throughout the exercise intervention regarding % completed vs. planned exercise intensity/session.",
                    "timeFrame": "Throughout the 12 weeks of supervised exercise training"
                },
                {
                    "measure": "Number of participants who experience adverse event as defined by most recent CTCAE",
                    "description": "To evaluate safety plans are in place for determination and monitoring of adverse events according to the most recent National Cancer Institute Common Terminology Criteria for Adverse Events. Classification for seriousness, expectedness, severity and relationship to study intervention will be based on the NIH provided definitions.",
                    "timeFrame": "Throughout the 12 weeks of supervised exercise training"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* diagnosis of primary invasive non-metastatic breast cancer, stages I-III\n* female based on biological sex\n* 40 to 80 years of age\n* completed breast cancer treatment 6 to 24 months prior to study enrollment. Adjuvant endocrine therapy for breast cancer (e.g., ovarian suppression, SERMs, SERDs, AIs), CDK4/6 inhibitors, PARP inhibitors, HER2 targeted agents, immunotherapy and bisphosphonates are allowed within 6 months prior to study enrollment and during study participation\n* absence of contraindications to exercise or study participation\n* study clinician approval\n\nExclusion Criteria:\n\n* do not meet inclusion criteria\n* receiving or scheduled to receive treatment for breast cancer (i.e., chemotherapy, surgery, or radiation) during study participation is not allowed. Adjuvant endocrine therapy, CDK4/6 inhibitors, PARP inhibitors, HER2 targeted agents, immunotherapy and bisphosphonates are allowed during study participation\n* lymphedema stage \u2265 2 prior to study enrolment\n* any relevant cardiovascular diseases (stroke, heart failure, myocardial ischemia during maximal graded exercise test, myocardial infarction, angina pectoris, coronary artery bypass surgery or angioplasty or coronary stent)\n* current participation in other experimental interventions that may confound interpretation of study findings (e.g., dietary intervention for weight loss)\n* consistent participation in \u2265150 min/week of moderate-intensity rowing exercise training in previous 6 months",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "minimumAge": "40 Years",
            "maximumAge": "80 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Demetra Christou, PhD",
                    "role": "CONTACT",
                    "phone": "352-294-1746",
                    "email": "ddchristou@ufl.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Demetra Christou, PhD",
                    "affiliation": "University of Florida",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Integrative Cardiovasculal Physiology Laboratory, University of Florida",
                    "status": "RECRUITING",
                    "city": "Gainesville",
                    "state": "Florida",
                    "zip": "32611",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Demetra Christou, PhD",
                            "role": "CONTACT",
                            "phone": "352-294-1746",
                            "email": "ddchristou@ufl.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.65163,
                        "lon": -82.32483
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001943",
                    "term": "Breast Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000001941",
                    "term": "Breast Diseases"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5220",
                    "name": "Breast Neoplasms",
                    "asFound": "Breast Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5218",
                    "name": "Breast Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}